Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02290327Phase 3Completed
Phase 3, randomised, double-blind trial in gastrointestinal bleeding comparing Pantoprazole with Placebo (2 arms). Primary endpoints: Consent Rate at 12 months, Recruitment Rate at 12 months and 1 more. Started May 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02290327.